Latta‐Mahieu, M., Elmer, B., Bretteville, A., Wang, Y., Lopez‐Grancha, M., Goniot, P., Moindrot, N., Ferrari, P., Blanc, V., Schussler, N., Brault, E., Roudières, V., Blanchard, V., Yang, Z., Barneoud, P., Bertrand, P., Roucourt, B., Carmans, S., Bottelbergs, A., Mertens, L., Wintmolders, C., Larsen, P., Hersley, C., McGathey, T., Racke, M. M., Liu, L., Lu, J., O'Neill, M. J., Riddell, D. R., Ebneth, A., Nabel, G. J., & Pradier, L. (2018). systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse models. Glia, 66(3), 492–504. http://access.bl.uk/ark:/81055/vdc_100055780633.0x00004c